Inventor
LI REN
Inventor
CN
Overview
Patents· 42 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C07DHeterocyclic compounds16%
A61KPreparations for medical, dental or toiletry purposes11%
H04RLoudspeakers, microphones, gramophone pick-ups or like acoustic electromechanical transducers7%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution5%
C07BGeneral methods of organic chemistry4%
E21BEarth or rock drilling4%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
H02JElectric power networks3%
A61LMethods or apparatus for sterilising materials or objects in general2%
PatentTitleYear
12,590,316Use of b-1,3-glucan synthase like 5 in improving clubroot disease resistance and related product development in cruciferous crops202612,568,336Loudspeaker202612,526,560Speaker box202612,452,580Speaker box and electronic device202512,413,912Sound device202512,374,897Medium-voltage photovoltaic grid-connected inverter system and photovoltaic power generation system202512,351,571Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases202512,356,173Sound device202512,356,172Loudspeaker202512,335,708Sound device202512,303,509Compounds for the treatment of BRAF-associated diseases and disorders202512,298,280Method for increasing number of proteins identified by mass spectrometry202512,297,300Hyaluronic acid-based zwitterionic polymer brush, preparation method thereof, and use thereof202512,252,942Rolling and sliding adaptive device for guiding and fixing drill pipe202512,240,8465- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases202512,227,413Composite loaded with nano-magnesium hydride and preparation method thereof202512,212,133Medium-voltage photovoltaic grid-connected inverter system and photovoltaic power generation system202512,180,207Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kinases202412,131,104Coupling numerical simulation method for site selection of underground salt cavern hydrogen storage202412,128,512Assembly method for deep in-situ high-fidelity coring calibration platform202412,130,646Real-time temperature-pressure detection and rapid processing system for calibration platform202412,126,180Medium-voltage photovoltaic grid-connection inverter system, and photovoltaic power generation system202412,085,100Bottom cylinder for high-temperature and high-pressure environment simulator202412,071,820High-temperature and high-pressure simulator for deep in-situ environment202411,998,545Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors202412,003,919Speaker box202411,964,988Fused heterocyclic compounds as RET kinase inhibitors202411,851,434Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors202311,807,6385- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases202311,807,649Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2202311,802,1273,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors202311,767,3215- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases202311,691,9733,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors202311,648,243Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors202311,634,409Compounds for the treatment of BRAF-associated diseases and disorders202311,603,374Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors202311,588,701Method and system for determining network slice topology, and device202311,534,969Single screw extrusion sprayer of a 3D printer202211,524,963Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors202211,472,802Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors202211,426,496Method for preparing anti-bacterial surface on medical material surface202211,414,404Compounds for the treatment of BRAF-associated diseases and disorders2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ARRAY BIOPHARMA INC (11)· patent assignee history
2022–2026Based in CN· patent location history
2022–2025Based in US· patent location history
2023–2025Patents assigned to ENLIVEN INC (3)· patent assignee history
2023–2025Patents assigned to PFIZER (3)· patent assignee history
2024–2026Patents assigned to AAC MICROTECH CHANGZHOU CO LTD (8)· patent assignee history
2024–2025Patents assigned to UNIV SICHUAN (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARRAY BIOPHARMA INC | 11 | 2022–2025 |
| AAC MICROTECH CHANGZHOU CO LTD | 8 | 2024–2026 |
| UNIV SICHUAN | 6 | 2024–2025 |
| ENLIVEN INC | 3 | 2023–2025 |
| PFIZER | 3 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 24 | 2022–2026 |
| US | 18 | 2022–2025 |